Symptoms of Long-COVID Can Last Up to Two Years After Infection, Say END-VOC Researchers
Almost one in four people infected with SARS-CoV-2 suffered from long-COVID, according to a population-based cohort study in Catalonia […]
T Cells Hold the Line Against New COVID-19 Variants
This study underscores the key role of T cells in providing long-term protection against evolving COVID variants […]
Mpox Outbreak in Africa Can Still be Controlled and Eliminated, Says END-VOC Leader
In a recent comment published in The Lancet, Ibrahim Abubakar and colleagues stress the importance of African leadership in effectively responding to the ongoing mpox outbreak […]
END-VOC Welcomes a New Partner to the Project
This summer, the Instituto de Medicina Molecular (IMM) Joao Lobo Antunes officially joined the ENDVOC project. In an interview, group leader Luis Graca explains how this partnership will allow to [...]
ENDVOC’s Fourth General Assembly in London Shows Great Progress
The ENDVOC consortium is now in a position to step up its cross-cohort analyses and to help fill gaps in key areas such as Long Covid and pandemic preparedness [...]
